Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

NCT06114628 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

2500

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Tuberculosis

Interventions

DRUG: Ganfeborole
DRUG: BTZ-043
DRUG: Bedaquiline (B)
DRUG: Delamanid (D)
DRUG: Pretomanid (Pa)
DRUG: Moxifloxacin (M)
DRUG: Linezolid (L)
DRUG: Pyrazinamide (Z)
DRUG: Rifampicin (R)
DRUG: Isoniazid (H)
DRUG: Ethambutol (E)
DRUG: Delpazolid (DZD)
DRUG: Quabodepistat (Q)

Sponsor

University College, London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]